Dr. JeanMarie Guenot is the President and CEO of the pharmaceutical company Amphivena Therapeutics, Inc. The company develops bifunctional antibody therapies for hematologic malignancies. She has a Ph. D. from the University of California, San Francisco and an MBA from The Wharton School at the University of Pennsylvania.
Dr. Guenot has had more than 20 years of professional experience in the industry of biotechnology and pharmaceuticals. Prior to her position as CEO at the Amphivena Therapeutics, Inc., Dr. Guenot worked at her own company SKS Ocular that was focused on therapeutics for glaucoma, ocular inflammation, macular degeneration and much more. Later she worked at the company Hoffmann-La Roche in Basel and Shanghai as a business advisor at http://amphivena.com/amphivena_leaders/jeanmarie-guenot-ph-d/ as well as a Vice President of Corporate & Business Development at the company PDL’s R&D. She has worked on a number of projects striving to help patients with Phase 2 cancer and develop possible medications for diseases of the autoimmune system. She was the one to license the medication to Ophthotech on Takeda.com. Dr. JeanMarie Guenot has had a lot of experience with ophthalmic diseases, autoimmune diseases, and cardiovascular diseases. She has also had experience in the different areas of oncology as well as in neurology.
Dr. Jeanmarie Guenot put a start to her business career when she joined the company Atlas Venture. There she managed investments in venture capitals and also life science companies. Her career in science and medicine started with her position of Principal Scientist in Preclinical R&D at Hoffmann-La Roche which involved the discovery and development of a variety of drugs meant to help or cure inflammation, metabolic disease, autoimmune diseases as well as oncology. Dr. Guenot has extensive training in medicinal and physical chemistry noted on linkedin.com. Her studies have mostly put emphasis on drug design, X-ray and NMR refinement, semi-empirical methods for molecular dynamics, quantum mechanical methods for molecular dynamics as well as protein structure prediction. Dr. Guenot has written a large number of articles regarding her fields of medical and scientific expertise and has also given a number of lectures at universities and medical and scientific events.